Pa sicrwydd y gall Llywodraeth Cymru ei roi y bydd arweinyddiaeth glinigol genedlaethol i wella iechyd a gwasanaethau cyhyrysgerbydol (MSK) yn cael ei ddarparu ar ôl i adolygiad mewnol presennol Perfformiad a Gwella GIG Cymru ddod i ben, gan gynnwys ar gyfer cyflyrau'r system gyhyrysgerbydol a reolir yn bennaf mewn gofal sylfaenol, fel osteoarthritis?
As I set out in my response to WQ99680, national clinical leadership arrangements for musculoskeletal (MSK) health are an operational matter for NHS Wales Performance and Improvement.
I understand NHS Wales Performance and Improvement is currently reviewing future national clinical leadership arrangements in this area and others. As that work is ongoing, I am unable to comment on future arrangements at this stage.
In the meantime, the National MSK Strategic Clinical Network continues to support improvements in services across primary, community and secondary care, including for people living with osteoarthritis and other MSK conditions. This includes the development of an all-Wales integrated service specification.